|
|
||||||||
a Department of Immunology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, Oslo, Norway;
b Institute of Medical Biochemistry, The University of Oslo, Oslo, Norway
Key Words. Hematopoiesis • Human • CD34+ cells • Erythropoiesis • Bcl-2 • Bcl-xL • Apoptosis
Dag Josefsen, M.D., Department of Immunology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, N-0310 Oslo, Norway. Telephone: 47-22-93-45-69; Fax: 47-22-50-07-30; e-mail: dag.josefsen{at}labmed.uio.no
The Bcl-2 family of proteins has been shown to play a central role in the regulation of apoptosis. We have examined the expression of several Bcl-2 homologs upon stimulation of CD34+ human hematopoietic progenitor cells. CD34+ cells were induced to differentiate into predominantly erythroid cells in the presence of erythropoietin (Epo) and stem cell factor (SCF), while the addition of G-CSF and SCF led to differentiation predominantly into granulocytic cells, as demonstrated by immunophenotyping and morphological examination of cultured cells. In Epo- and SCF-stimulated cells, we found a marked increase in the level of Bcl-xL protein expression and downregulation of Bax expression, apparent from day 4 and more pronounced on days 8 and 21. In contrast, Bcl-xL protein expression was downregulated in G-CSF- and SCF-stimulated cells compared with cells cultured in medium alone, whereas there was no sign of change in the level of Bax. Mcl-1 expression showed a biphasic expression pattern in both early erythropoiesis and early granulopoiesis, but with an inverse regulation. Thus, Mcl-1 levels initially decreased in granulocytic progenitor cells and increased in erythroid progenitor cells. Finally, Bcl-2 expression was significantly downregulated in both Epo and SCF and G-CSF- and SCF-stimulated cells.
The role of the distinct upregulation of Bcl-xL in early erythroid differentiation was further examined by use of specific ribozymes against Bcl-xL. Addition of Bcl-xL ribozymes promoted a clear increase in cell death of Epo- and SCF-stimulated cells, while erythroid differentiation was not affected. In conclusion, we found a distinct regulation of several Bcl-2 family members in CD34+ cells dependent on the cytokine stimulation given. The use of Bcl-xL-specific ribozymes suggested that Bcl-xL is important for survival but not for differentiation of erythroid progenitor cells.
This article has been cited by other articles:
![]() |
M. A. Kerenyi, F. Grebien, H. Gehart, M. Schifrer, M. Artaker, B. Kovacic, H. Beug, R. Moriggl, and E. W. Mullner Stat5 regulates cellular iron uptake of erythroid cells via IRP-2 and TfR-1 Blood, November 1, 2008; 112(9): 3878 - 3888. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kiani, I. Habermann, M. Haase, S. Feldmann, S. Boxberger, M. A. Sanchez-Fernandez, C. Thiede, M. Bornhauser, and G. Ehninger Expression and regulation of NFAT (nuclear factors of activated T cells) in human CD34+ cells: down-regulation upon myeloid differentiation J. Leukoc. Biol., November 1, 2004; 76(5): 1057 - 1065. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Carlsson, A. A. G. Aprikyan, R. Tehranchi, D. C. Dale, A. Porwit, E. Hellstrom-Lindberg, J. Palmblad, J.-I. Henter, and B. Fadeel Kostmann syndrome: severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells Blood, May 1, 2004; 103(9): 3355 - 3361. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Aerbajinai, M. Giattina, Y. T. Lee, M. Raffeld, and J. L. Miller The proapoptotic factor Nix is coexpressed with Bcl-xL during terminal erythroid differentiation Blood, July 15, 2003; 102(2): 712 - 717. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Haughn, R. G. Hawley, D. K. Morrison, H. von Boehmer, and D. M. Hockenbery BCL-2 and BCL-XL Restrict Lineage Choice during Hematopoietic Differentiation J. Biol. Chem., June 27, 2003; 278(27): 25158 - 25165. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-J. Lataillade, D. Clay, P. Bourin, F. Herodin, C. Dupuy, C. Jasmin, and M.-C. Le Bousse-Kerdiles Stromal cell-derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G0/G1 transition in CD34+ cells: evidence for an autocrine/paracrine mechanism Blood, February 15, 2002; 99(4): 1117 - 1129. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
